Clinical trials
Phase 1 Carcinoma, Non-Small-Cell Lung trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
107 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 5 |
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 7 |
| 2017 | 10 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 13 |
| 2023 | 5 |
| 2024 | 11 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Active, not recruiting | 20 |
| Recruiting | 19 |
| Terminated | 18 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 13 |
| Pfizer | 8 |
| AstraZeneca | 5 |
| Bristol-Myers Squibb | 5 |
| Seagen, a wholly owned subsidiary of Pfizer | 5 |
| AbbVie | 4 |
| Bayer | 4 |
| GlaxoSmithKline | 4 |
| Amgen | 3 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 107 |
| Colorectal Neoplasms | 28 |
| Neoplasms | 28 |
| Melanoma | 24 |
| Lung Neoplasms | 20 |
| Squamous Cell Carcinoma of Head and Neck | 20 |
| Ovarian Neoplasms | 17 |
| Triple Negative Breast Neoplasms | 16 |
| Stomach Neoplasms | 15 |
| Breast Neoplasms | 13 |
Trials
Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.
7 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.